Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine

Human Immunology

Volumn 66, Issue 7, 2005, Pages 788-798

  St Sauver, Jennifer L ^a   Dhiman, Neelam ^b   Ovsyannikova, Inna G ^a   Jacobson, Robert M ^a   Vierkant, Robert A ^a   Pankratz, V Shane ^a   Jacobsen, Steven J ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Cellular immunity; HLA; Homozygosity; Humoral immunity; MMR

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MUMPS ANTIBODY; RUBELLA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE LOCUS; HETEROZYGOSITY; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MALE; MEASLES; MUMPS; NORMAL HUMAN; PRIORITY JOURNAL; RUBELLA;

ANTIBODIES; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HETEROZYGOTE; HLA ANTIGENS; HOMOZYGOTE; HUMANS; IMMUNITY, CELLULAR; INFANT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; RUBELLA;

EID: 23844558901     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.03.008     Document Type: Article

References (35)

1. V. Apanius, D. Penn, P.R. Slev, L.R. Ruff, W.K. Potts The nature of selection on the major histocompatibility complex Crit Rev Immunol 17 1997 179
2. A.M. Borghans, J.B. Beltman, R.J. De Boer MHC polymorphism under host-pathogen coevolution Immunogenetics 55 2004 732
3. J. Klein, A. Sato The HLA system. First of two parts N Engl J Med 343 2000 702
4. J. Klein, A. Sato The HLA system. Second of two parts N Engl J Med 343 2000 782 Erratum appears in N Engl J Med 2000;343:1504
5. D.J. Penn, K. Damjanovich, W.K. Potts MHC heterozygosity confers a selective advantage against multiple-strain infections Proc Natl Acad Sci U S A 99 2002 11260
6. M. Carrington, G.W. Nelson, M.P. Martin, T. Kissner, D. Vlahov, J.J. Goedert, R. Kaslow, S. Buchbinder, K. Hoots, S.J. O'Brien HLA and HIV-1 heterozygote advantage and B*35-Cw*04 disadvantage [see comments] Science 283 1999 1748
7. J. Tang, C. Costello, I.P. Keet, C. Rivers, S. Leblanc, E. Karita, S. Allen, R.A. Kaslow HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection AIDS Res Hum Retroviruses 15 1999 317
8. M.R. Thursz, H.C. Thomas, B.M. Greenwood, A.V. Hill Heterozygote advantage for HLA class-II type in hepatitis B virus infection [letter] [published erratum appears in Nat Genet 1998;18:88] Nat Genet 17 1997 11
9. M.R. Thursz Host genetic factors influencing the outcome of hepatitis J Viral Hepat 4 1997 215
10. K.J. Jeffery, A.A. Siddiqui, M. Bunce, A.L. Lloyd, A.M. Vine, A.D. Witkover, S. Izumo, K. Usuku, K.I. Welsh, M. Osame, C.R. Bangham The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection J Immunol 165 2000 7278
11. J.L. St Sauver, I.G. Ovsyannikova, R.M. Jacobson, S.J. Jacobsen, R.A. Vierkant, D.J. Schaid, V.S. Pankratz, E.M. Green, G.A. Poland Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine J Infect Dis 185 2002 1545
12. I.G. Ovsyannikova, R.M. Jacobson, R.A. Vierkant, S.J. Jacobsen, V.S. Pankratz, G.A. Poland The contribution of HLA class I antigens in immune status following two doses of rubella vaccination Hum Immunol 65 2004 1506
13. I.G. Ovsyannikova, R.M. Jacobson, R.A. Vierkant, S.J. Jacobsen, V.S. Pankratz, G.A. Poland HLA class II alleles and rubella-specific humoral and cell-mediated immunity following MMR-II vaccination J Infect Dis 191 2005 515
14. N. Bautista-Lopez, B.J. Ward, E. Mills, D. McCormick, N. Martel, S. Ratnam Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination Vaccine 18 2000 1393
15. P.J. Enrietto, L.N. Payne, M.J. Hayman A recovered avian myelocytomatosis virus that induces lymphomas in chickens pathogenic properties and their molecular basis Cell 35 2 Pt 1 1983 369
16. L. Fugger, N. Morling, L.P. Ryder, N. Odum, A. Svejgaard Technical aspects of typing for HLA-DP alleles using allele-specific DNA in vitro amplification and sequence-specific oligonucleotide probes detection of single base mismatches J Immunol Methods 129 1990 175
17. A. Kimura, R.P. Dong, H. Harada, T. Sasazuki DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA Tissue Antigens 40 1992 5
18. O. Olerup, A. Aldener, A. Fogdell HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours Tissue Antigens 41 1993 119
19. O. Olerup, H. Zetterguist DR "low-resolution" PCR-SSP typing - a correction and an update [letter; comment] Tissue Antigens 41 1993 55
20. C.M. Weyand, C. Xie, J.J. Goronzy Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis J Clin Invest 89 1992 2033
21. G.A. Poland, R.M. Jacobson, D. Schaid, S.B. Moore, S.J. Jacobsen The association between HLA class I alleles and measles vaccine-induced antibody response evidence of a significant association Vaccine 16 1998 1869
22. A.B. McDermott, S.B. Cohen, J.N. Zuckerman, J.A. Madrigal Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine Vaccine 17 1999 330
23. P.A. Brunell, K. Weigle, M.D. Murphy, Z. Shehab, E. Cobb Antibody response following measles-mumps-rubella vaccine under conditions of customary use JAMA 250 1983 1409
24. L.A. Mitchell, A.J. Tingle, D. Decarie, C. Lajeunesse Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR Can J Public Health 89 1998 325
25. D.O. Matson, C. Byington, M. Canfield, P. Albrecht, R.D. Feigin Investigation of a measles outbreak in a fully vaccinated school population including serum studies before and after revaccination Pediatr Infect Dis J 12 1993 292
26. N. Boulianne, G. De Serres, S. Ratnam, B.J. Ward, J.R. Joly, B. Duval Measles, mumps, and rubella antibodies in children 5-6 years after immunization effect of vaccine type and age at vaccination Vaccine 13 1995 1611
27. C.E. Johnson, M.L. Kumar, J.K. Whitwell, B.O. Staehle, L.P. Rome, C. Dinakar, W. Hurni, D.R. Nalin Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs eleven to thirteen years Pediatr Infect Dis J 15 1996 687
28. M.L. Cohn, E.D. Robinson, M. Faerber, D. Thomas, S. Geyer, S. Peters, M. Martin, A. Martin, D. Sobel, R. Jones, L. Larkin, J.R. Richert Measles vaccine failures lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults Pediatr Infect Dis J 13 1994 34
29. G.A. Poland, R.M. Jacobson, A.M. Thampy, S.A. Colbourne, P.C. Wollan, J.J. Lipsky, S.J. Jacobsen Measles reimmunization in children seronegative after initial immunization JAMA 277 1997 1156
30. A.B. McDermott, J.A. Madrigal, C.A. Sabin, J.N. Zuckerman, S.B. Cohen The influence of host factors and immunogenetics on lymphocyte responses to Hepagene vaccination Vaccine 17 1999 1329
31. E. Celis, D. Ou, L. Otvos Jr Recognition of hepatitis B surface antigen by human T lymphocytes proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides J Immunol 140 1988 1808
32. E. Celis, R.W. Karr Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule J Virol 63 1989 747
33. S. Ratnam, V. Gadag, R. West, J. Burris, E. Oates, F. Stead, N. Bouilianne Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody J Clin Microbiol 33 1995 811
34. N.E. Cremer, C.K. Cossen, G. Shell, J. Diggs, D. Gallo, N.J. Schmidt Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses J Clin Microbiol 21 1985 869
35. V.A. de Souza, C.S. Pannuti, L.M. Sumita, H.F. de Andrade Junior Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines J Med Virol 52 1997 275